Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 9;36(2):169-187.
doi: 10.1515/revneuro-2024-0065. Print 2025 Feb 25.

Neurobiological mechanisms in the kynurenine pathway and major depressive disorder

Amanda Gollo Bertollo  1 , Maiqueli Eduarda Dama Mingoti  1 , Zuleide Maria Ignácio  1
Affiliations
Review

Neurobiological mechanisms in the kynurenine pathway and major depressive disorder

Amanda Gollo Bertollo et al. Rev Neurosci. .

Abstract

Major depressive disorder (MDD) is a prevalent psychiatric disorder that has damage to people's quality of life. Tryptophan is the precursor to serotonin, a critical neurotransmitter in mood modulation. In mammals, most free tryptophan is degraded by the kynurenine pathway (KP), resulting in a range of metabolites involved in inflammation, immune response, and neurotransmission. The imbalance between quinolinic acid (QA), a toxic metabolite, and kynurenic acid (KynA), a protective metabolite, is a relevant phenomenon involved in the pathophysiology of MDD. Proinflammatory cytokines increase the activity of the enzyme indoleamine 2,3-dioxygenase (IDO), leading to the degradation of tryptophan in the KP and an increase in the release of QA. IDO activates proinflammatory genes, potentiating neuroinflammation and deregulating other physiological mechanisms related to chronic stress and MDD. This review highlights the physiological mechanisms involved with stress and MDD, which are underlying an imbalance of the KP and discuss potential therapeutic targets.

Keywords: kynurenine; major depressive disorder; neuroinflammatory diseases; synaptic transmission.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Agudelo, L.Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J.C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al.. (2014). Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159: 33–45, https://doi.org/10.1016/j.cell.2014.07.051 . - DOI
    1. Allen, A.P., Naughton, M., Dowling, J., Walsh, A., Ismail, F., Shorten, G., Scott, L., McLoughlin, D.M., Cryan, J.F., Dinan, T.G., et al.. (2015). Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT. J. Affect. Disord. 186: 306–311, https://doi.org/10.1016/j.jad.2015.06.033 . - DOI
    1. Alonso-Lana, S., Marquié, M., Ruiz, A., and Boada, M. (2020). Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Front. Aging Neurosci. 12: 588872, https://doi.org/10.3389/fnagi.2020.588872 . - DOI
    1. Banerjee, J., Alkondon, M., Pereira, E.F.R., and Albuquerque, E.X. (2012). Regulation of GABAergic inputs to CA1 pyramidal neurons by nicotinic receptors and kynurenic acid. J. Pharmacol. Exp. Ther. 341: 500–509, https://doi.org/10.1124/jpet.111.189860 . - DOI
    1. Bay-Richter, C., Linderholm, K.R., Lim, C.K., Samuelsson, M., Träskman-Bendz, L., Guillemin, G.J., Erhardt, S., and Brundin, L. (2015). A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality. Brain. Behav. Immun. 43: 110–117, https://doi.org/10.1016/j.bbi.2014.07.012 . - DOI

MeSH terms

LinkOut - more resources